Bausch & Lomb (BLCO) Non-Current Debt (2022 - 2026)
Bausch & Lomb's (BLCO) quarterly Non-Current Debt came in at $5.1 billion in Q2 2026, up 2.38% on a YoY basis from $5.0 billion in Q2 2025, and up 0.75% quarter-over-quarter from $5.0 billion in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Non-Current Debt (2022 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Non-Current Debt for 5 consecutive years, with $5.1 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Debt rose 2.38% year-over-year to $5.1 billion; the trailing twelve-month figure through Jun 2026 stood at $5.1 billion (up 2.38% YoY), and the FY2025 full-year result was $5.0 billion, up 5.52% from the prior year.
- Non-Current Debt grew to $5.1 billion in Q2 2026 per BLCO's latest filing, from $5.0 billion in the prior quarter.
- Across five years, Non-Current Debt topped out at $5.1 billion in Q2 2026 and bottomed at $2.2 billion in Q1 2022.
- Historically, Non-Current Debt has averaged $4.0 billion across 5 years, with a median of $4.6 billion in 2024.
- The sharpest annual moves came in 2023 and 2026: Non-Current Debt surged 87.27% in 2023, then grew 2.38% in 2026.
- Over 5 years, Non-Current Debt stood at $2.4 billion in 2022, then soared by 87.27% to $4.6 billion in 2023, then climbed by 4.87% to $4.8 billion in 2024, then increased by 5.52% to $5.0 billion in 2025, then rose by 0.57% to $5.1 billion in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $5.1 billion, $5.0 billion, and $5.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 25.62 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 14.19 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 10.92 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 598.70 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 5.08 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.08 Bn |
| Mar 31, 2026 | 5.04 Bn |
| Dec 31, 2025 | 5.05 Bn |
| Sep 30, 2025 | 4.95 Bn |
| Jun 30, 2025 | 4.96 Bn |
| Mar 31, 2025 | 4.83 Bn |
| Dec 31, 2024 | 4.78 Bn |
| Sep 30, 2024 | 4.63 Bn |
| Jun 30, 2024 | 4.63 Bn |
| Mar 31, 2024 | 4.58 Bn |
| Dec 31, 2023 | 4.56 Bn |
| Sep 30, 2023 | 4.47 Bn |
| Jun 30, 2023 | 2.60 Bn |
| Mar 31, 2023 | 2.51 Bn |
| Dec 31, 2022 | 2.44 Bn |
| Sep 30, 2022 | 2.41 Bn |
| Jun 30, 2022 | 2.42 Bn |
| Mar 31, 2022 | 2.22 Bn |